Spotlight Asset Group’s Elevance Health ELV Stock Holding History

Spotlight Asset Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$20.6K	Hold	38	–	–	0.01%	166
2024 Q1	$19.7K	Sell	38 -190	-83%	-$94.5K	0.01%	173
2023 Q4	$99.3K	Hold	228	–	–	0.09%	96
2023 Q3	$99.3K	Sell	228 -133	-37%	-$60.3K	0.09%	96
2023 Q2	$160K	Buy	+361	New	+$167K	0.14%	72
2021 Q3	$221K	Sell	594 -113	-16%	-$42.9K	0.11%	107
2021 Q2	$270K	Buy	707 +44	+7%	+$16.8K	0.1%	104
2021 Q1	$238K	Buy	+663	New	+$213K	0.09%	110
2020 Q4	–	Sell	-864	Closed	-$232K	–	144
2020 Q3	$232K	Sell	864 -112	-11%	-$30.1K	0.09%	122
2020 Q2	$257K	Sell	976 -62	-6%	-$16.5K	0.11%	106
2020 Q1	$236K	Hold	1,038	–	–	0.13%	94
2019 Q4	$252K	Buy	+1,038	New	+$286K	0.12%	96

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Spotlight Asset Group's ELV Position: Q2 2024 in Review

Spotlight Asset Group held its Elevance Health (ELV) position steady in Q2 2024 at 38 shares worth $20.6K. The position accounts for 0.01% of the portfolio, ranked #166.

Spotlight Asset Group first reported a position in ELV in Q4 2019 and has held it in 12 quarters since. The position peaked at $270K in Q2 2021. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

Spotlight Asset Group held 38 shares of Elevance Health worth $20.6K as of Q2 2024.
Spotlight Asset Group left its Elevance Health share count unchanged in Q2 2024.
Elevance Health made up 0.01% of Spotlight Asset Group's portfolio in Q2 2024, its #166 holding.
Spotlight Asset Group first reported a position in Elevance Health in Q4 2019 and has held it in 12 quarters since.
Spotlight Asset Group's Elevance Health position peaked at $270K in Q2 2021.
1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.